![Caroline Loew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Caroline J.
Loew worked at Bristol Myers Squibb Co. as Vice President & Head-Research from 2015 to 2018.
From 2018 to 2022, Dr. Loew was President, Chief Executive Officer & Director at Glympse Bio, Inc. Dr. Loew served as Director at Mural Oncology Plc in 2023.
Dr. Loew completed undergraduate and doctorate degrees at Imperial College London.
Tidigare kända positioner av Caroline Loew
| Företag | Position | Slut |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Verkställande Direktör | 2022-08-01 |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2018-10-01 |
Caroline Loews utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
